New Key Statistics Module, Z-Score and F-Score
NAS:CALT Key Ratios
| Market Cap $ M | 601.75 |
| Enterprise Value $ M | 620.74 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 909.09 |
| Price/Book | 51.14 |
| Price/Sales | 4.69 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 123.00 |
| EPS (TTM) $ | -1.83 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -36.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -15.58 |
| EV-to-EBITDA | -15.58 |
| PEG | -- |
| Shares Outstanding M | 26.84 |
| Net Margin (%) | -40.03 |
| Operating Margin % | -33.04 |
| Pre-tax Margin (%) | -37.86 |
| Quick Ratio | 2.62 |
| Current Ratio | 2.69 |
| ROA % (ttm) | -30.56 |
| ROE % (ttm) | -160.04 |
| ROIC % (ttm) | -74.30 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.85 |
CALT Number of Guru Trades
CALT Volume of Guru Trades
Gurus Latest Trades with NAS:CALT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CALT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Calliditas Therapeutics AB Insider Transactions
No Available Data
News about NAS:CALT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers